Brainscape's Knowledge GenomeTM


Top Flashcards (Certified)
All Flashcards

PHS 933 > Block 2 Lecture 4 -- Menopause and HRT > Flashcards

Block 2 Lecture 4 -- Menopause and HRT Flashcards

1
Q

What is the definition of menopause?

A

12 consecutive months of amenorrhea via cessation of ovarian follicular activity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What is the median age of menopause in the US?

A

51 (2 years earlier if smoker or hysterectomy)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What are the hormonal changes in menopause?

A

1) estrogen, progesterone decrease
2) FSH and LH increase
3) ovaries primarily produce androgens
4) SHBG decreases, generating increased free T, but overall less total T

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What is perimenopause?

A

the period preceding menopause by 2-4 years and the year following menopause

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What are the symptoms of menopause?

A

1) vasomotor
2) mood changes, anxiety
3) sleep disturbances
4) vaginal dryness

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

When do menopausal symptoms begin?

A

perimenopause

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Describe the enrollment in the WHI ‘91 study.

A

160k post-menopausal women aged 50-79

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

How long was the WHI study run?

A

15 years

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What are the interventions in the WHI study?

A

1) HRT
2) d-mod
3) D + Ca

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Describe the drugs given as HRT in the WHI study.

A

CEE 0.625mg/day

+ MPA 2.5 mg/day if uterus intact

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Why was the HRT arm halted?

A

increased stroke risk with no effect on CHD

combo increased risk of breast cancer

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

When was the HRT arm halted?

A

combo after 5 years

e only after 7 years

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Describe the interventions in the d-mod arm of WHI?

A

1 g/day Ca + 400 IU/day Vit. D

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What were the expectations in the Ca/D arm of the WHI study?

A

1) decreased bone fx
2) decreased colorectal cancer risk
3) increase kidney stones

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Describe the interventions in the d-mod arm of WHI.

A

low-fat diet (less than 20% of calories) resulting in a 10% fat reduction vs. control

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What were the criticisms of the WHI study?

A

1) low adherence, high attrition
2) under-reported benefits
3) average as was 63

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

What did sub-group analysis of the WHI study conclude?

A

HRT not harmful if initiated early

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

What were the under-reported benefits of the WHI study?

A
    • decreased total mortality
    • decreased colorectal/endometrial cancer
    • decreased hip and total fx
    • decreased t2dm and PAD
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

What did outside analysis of the WHI study conclude?

A

window of opportunity for max effect of HRT on total mortality and CHD:

    • within 6 years of menopause and/or before age 60
    • continue for 5+ years
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Describe the enrollment in the Danish Osteoporosis Prevention Study

A

1006 peri-menopausal women (u-60 yo) randomized to combined HRT (or estrogen only)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

How long was the Danish Osteoporosis Prevention study conducted?

A

treated for 10 years

followed for 16

22
Q

What was the conclusion of the Danish Osteoporosis Prevention Study?

A 
significantly reduced risk of:
-- mortality,
-- heart failure
-- MI
without increased risk of:
-- cancer
-- thromboembolism
-- stroke
23
Q

What are the goals of menopause treatment?

A

1) relieve vasomotor symptoms in the short term (5-years)

2) prevent osteoporosis in the long term

24
Q

What is the standard dose of CEE?

A

0.625 mg/day

25
Describe the content of CEE
50-60% estrone sulfate | -- remainder = other equine estrogens
26
What is the most popular oral estrogen in the US?
premarin (CEE)
27
How much of the oral estrogen forms reach circulation as free estradiol?
less than 10% | -- estrones are converted back to estradiol over time
28
Describe the absorption of estradiol?
during absorption, intestinal mucosa and liver convert to estrones
29
What estrogen form gives the most physiologic (pre-menopause) E2:E1 ratio?
transdermal estrogen patch
30
How is the IN estrogen spray dosed?
1-2 x/day
31
What are the forms of parenteral estrogen?
1) patch/gels/creams 2) sq implant 3) intranasal spray 4) vaginal rings
32
How often do estrogen-containing vaginal rings last?
3 months
33
Which parenteral estrogens are effective (increase BMD and relieve vasomotor sxs) at low doses?
transdermal, vaginal ring
34
Which parenteral estrogen is least likely to have ADRs?
transdermal
35
What are the drug interactions for estrogens?
1) anticonvulsants (induce 3A4) | 2) may increase THBG, CBG, SHBG
36
What are the forms of progesterone used in menopause?
1) micronized (prometrium) 2) levonorgestrel IUD (mirena, skyla) 3) drosperinone
37
Why are progestogens always included with estrogens?
to prevent endometrial hyperplasia and cancer
38
What are the effects of progesterone on estrogens?
1) decrease nuclear ER concentration | 2) promote conversion of estradiol to estrone
39
What are the estrogen-progestogen regimens used in menopause?
1) continuous cyclic 2) continuous combined 3) continuous long-cycle 4) intermittent combined others - - lo-dose - - quarterly progestogen
40
Describe the continuous cyclic regimen.
E daily + P last 12-14 days - - results in withdrawal bleed 90% of patients - - oral or TD
41
Describe the continuous combined regimen.
E + P continuously - - oral or TD - - endometrial atrophy and amenorrhea - - unpredictable spotting/bleeding initially, resolved within 6-12 months - - usually reserved for recent menopause (2 years past)
42
How may spotting be stopped in the continuous combined regimen?
increase P or decrease E
43
Describe the continuous long-cycle regimen.
E daily + P q other month x 12-14 days | -- longer heavier bleeding than continuous cycling
44
Describe the intermittent combined regimen.
-- 3 days E -- then 3 days E+P -- repeat results in decreased incidence of bleeding lower P dose = fewer ADRs
45
Describe low-dose HRT
0. 45 mg CEE + 1.5 mg MPA | - - maintains sx relief and BMD
46
Describe quarterly progestogen regimen in HRT.
MPA x 14 days q 3 months | -- higher incidence of endometrial hyperplasia
47
What are the ADRs of progesterone?
1) irritability 2) depression 3) HA 4) sleep disturbance 5) bloating
48
What is drosperinone?
anti-androgenic P with anti-MR effects - - decreased hyperplasia - - no hyperkalemia
49
What are the results of levonorgestrel IUD therapy?
off-label HRT use: - - atrophic endometrium - - low systemic P levels
50
What are the effects of micronized progesterone therapy?
- - less bleeding | - - does not improve lipids

PHS 933 (14 decks)

Brainscape helps you reach your goals faster, through stronger study habits.
© 2025 Bold Learning Solutions. Terms and Conditions